glp-1 drug list Market Overview: Agonists and the Obesity Market | Blog You've reached your weight loss

Learn how low-dose semaglutide and tirzepatide may support metabolism, menopause, inflammation, and autoimmune health.

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

Learn what GLP-1 medications are, how they work, and which conditions they are used to treat.

Tirzepatide was more efficacious in reducing body weight

A small human proof-of-concept trial reported that semaglutide reduced vastus lateralis cross-sectional area but did not reduce knee-extension strength or grip strength over 12 weeks